Honghao Guo – InmunoES

Disease-specific heterogeneity of C-reactive protein across 21 hematologic disorders reflects divergent inflammatory and hematopoietic phenotypes

17 de September de 2026 by Honghao Guo

BackgroundC-reactive protein (CRP) is routinely used to quantify systemic inflammation, yet its interpretation in hematologic disorders is complicated by marked biological heterogeneity. We characterized pretreatment CRP distributions across a broad he…

Correction: Efficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials with clinical implications for patient stratification and treatment optimization

11 de September de 2026 by Honghao Guo

Efficacy and safety of mesenchymal stem cell transplantation for progressive multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials with clinical implications for patient stratification and treatment optimization

22 de July de 2026 by Honghao Guo

BackgroundProgressive multiple sclerosis (PMS) is a disabling demyelinating disease characterized by irreversible neurodegeneration. Unlike relapsing-remitting MS, for which many disease-modifying therapies exist, treatment options for PMS are extremel…